May 4, 2022 CBD Company Cited For Claims Made in Blogs and Socials Takeaway - Blogs on a commercial website are marketing claims
April 27, 2022 Product Tags & Metatags Attract FDA Attention Takeaway - Everything used to market products must be compliant
April 20, 2022 Best Practices For Reducing Risk in Blogs Takeaway - Blogs can easily cross the line from “education” to “disease claims”
April 13, 2022 LinkedIn Posts Mentioned in Warning Letter Takeaway - All social media is “fair game” for enforcement
April 6, 2022 6-Year-Old Social Media Posts & Hashtags in Warning Letter Takeaway - Uncompliant hashtags attract FDA attention
March 30, 2022 7 CBD Companies Cited for Implied COVID claims Takeaway - Citing clinical studies on a commercial website is high risk
March 22, 2022 Online company fined $4.2M for blocking negative product reviews Takeaway - Product reviews must be honest and truthful
March 9, 2022 Product catalogs are considered extensions of the label Takeaway - Remove high-risk claims in all marketing materials
March 2, 2022 Discussing ingredient benefits is a marketing claim Takeaway - Replace high-risk words on a commercial website
February 23, 2022 “Blood sugar” enforcement risks and review Takeaway - Use caution when promoting blood sugar products. Remove claims on social media.
February 16, 2022 Learning targets: Old social media posts, hashtags, sketchy ingredients, and high-risk claims Takeaway - Hashtags can make compliant posts very non-compliant